Nebilet Plus (Hydrochlorothiazide, Nebivolol)

Nebivolol/Hydrochlorothiazide, the active ingredients in Nebilet Plus, are a beta‑blocker and a thiazide diuretic presented as an oral tablet for oral use. The combination lowers blood pressure by reducing heart rate and cardiac output while promoting sodium excretion, providing a synergistic approach to managing hypertension in adult patients.

GNH USA supplies Nebilet Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality manufacturing standards and reliable distribution across global markets for the treatment of cardiovascular conditions.

Nebilet Plus, a combined beta‑blocker and thiazide diuretic, is indicated for conditions related to elevated blood pressure.

- Essential hypertension: lowers blood pressure in patients with primary high blood pressure. - Primary hypertension: provides combined heart‑rate reduction and diuretic effect to achieve target pressures. - Hypertensive patients requiring combination therapy: offers a single‑tablet regimen to improve adherence.

Nebilet Plus may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness: light‑headedness especially after standing. - Headache: mild to moderate intensity. - Fatigue: general tiredness. - Increased urination: due to diuretic effect. - Electrolyte imbalance: mild changes in potassium or sodium. - Cough: occasional dry cough.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure. - Acute kidney injury: sudden decline in renal function. - Electrolyte disturbances: significant hyperkalemia or hyponatremia. - Bradycardia: excessively slow heart rate. - Allergic reactions: rash, itching, or angioedema. - Pancreatitis: rare inflammation of the pancreas.

When prescribing Nebilet Plus, clinicians should consider several precautionary measures to ensure safe use.

- Monitor blood pressure: check regularly after initiation and dose changes. - Assess renal function: evaluate creatinine and eGFR before and during therapy. - Check electrolyte levels: especially potassium and sodium, adjust as needed. - Caution in patients with asthma: β1‑selectivity may still affect bronchial tone. - Avoid abrupt discontinuation: taper to prevent rebound hypertension. - Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Nebilet Plus can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Strong CYP2D6 inhibitors: may increase nebivolol plasma levels. - Other antihypertensives: additive blood pressure lowering leading to hypotension. - Lithium: thiazide component reduces lithium clearance, risking toxicity.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt diuretic effect and affect renal function. - Antidiabetic drugs: diuretic may alter glucose control. - Calcium channel blockers: may enhance bradycardia. - Digoxin: increased serum levels due to reduced clearance.